MODERN METHODS OF DIAGNOSTICS OF LYSOSOMAL STORAGE DISEASES
Main Article Content
Authors
A. Konarbayeva
National Center for Biotechnology, 13/5 Korgalzhyn Highway, Astana, 010000, Kazakhstan
P.V. Tarlykov
National Center for Biotechnology, 13/5 Korgalzhyn Highway, Astana, 010000, Kazakhstan
Abstract
Lysosomal storage diseases, such as Gaucher, Niemann-Pick, Pompe, Krabbe, Fabry, and Mucopolysaccharidoses, are a group of more than 50 rare inherited metabolic diseases caused by dysfunction of lysosomes due to deficiency of specific enzymes. The early and accurate diagnosis of lysosomal storage diseases is important for the correct drug administration, genetic counseling, and prevention of severe complications. In Kazakhstan, the diagnosis of lysosomal storage diseases is difficult due to limited laboratory capabilities and low prevalence of these diseases among the population. This review discusses modern diagnostic methods, including tandem mass spectrometry, next-generation sequencing, and enzymatic activity tests. For forehanded diagnosis of lysosomal storage diseases, it is important to integrate molecular, genetic, and biochemical diagnostic methods, as well as develop national newborn screening programs.
Keywords
orphan disease, lysosomal storage disease, Gaucher disease, diagnostics, mass spectrometry
Article Details
References
Elbin C.S., Olivova P., Marashio C.A. et al. The effect of preparation, storage and shipping of dried blood spots on the activity of five lysosomal enzymes // Clinica Chimica Acta. ‒ 2011. ‒ Vol.412, №13. ‒ P.1207-1212.
Amangeldieva A.A A.G.K., Boranbayeva R.Z., Shimanskiy A Tilki, Tashenova G.T. Clinical and Diagnostic Characteristics of Children with Gaucher Disease in the Republic of Kazakhstan // American Journal of Rare Disorders: Diagnosis & Therapy. ‒ 2020. ‒ Vol.3, №1. ‒ P.024-030.
Müller K.B., Rodrigues M.D.B., Pereira V.G. et al. Reference values for lysosomal enzymes activities using dried blood spots samples - a Brazilian experience // Diagnostic Pathology. ‒ 2010. ‒ Vol.5, №1. ‒ P.65.
P.V N. Lysosomal storage diseases: The topical problem of pediatrics and the current possibilities of pathogenetic treatment // Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). ‒ 2014. ‒ Vol.59, №4. ‒ P.4-9.
Cainelli F. N.D., Izgutdina A., Kutabay G. Personalized diagnosis of Gaucher disease in Kazakhstan. ‒ 2017. ‒ URL: URL.
Anderson S. Newborn Screening for Lysosomal Storage Disorders // Journal of Pediatric Health Care. ‒ 2018. ‒ Vol.32, №3. ‒ P.285-294.
Feng S., Rcheulishvili N., Jiang X. et al. A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach // International Journal of Biological Sciences. ‒ 2024. ‒ Vol.20, №6. ‒ P.2111-2129.
Lei K., Zhao Y., Sun L. et al. A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of China // Orphanet Journal of Rare Diseases. ‒ 2018. ‒ Vol.13, №1. ‒ P.48.
Marsden D., Levy H. Newborn screening of lysosomal storage disorders // Clin Chem. ‒ 2010. ‒ Vol.56, №7. ‒ P.1071-1079.
Onlaın rejıme proshel semınar po boleznıý GOShE / Naýchnyı tsentr pedıatrıı ı detskoı hırýrgıı. ‒ Almaty, 26 Ianvarıa 2021.
Chamoles N.A., Blanco M., Gaggioli D. et al. Gaucher and Niemann-Pick diseases--enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards // Clin Chim Acta. ‒ 2002. ‒ Vol.317, №1-2. ‒ P.191-197.
Dardis A., Michelakakis H., Rozenfeld P. et al. Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1 // Orphanet Journal of Rare Diseases. ‒ 2022. ‒ Vol.17, №1. ‒ P.442.
Amangeldıeva A.A. B.R.Z., Abdılova G.K. Klınıko-dıagnostıcheskıe osobennostı Boleznı Goshe v Kazahstanskoı popýlıatsıı // Farmaciâ Kazahstana. ‒ 2024. ‒ Vol.6, №257. ‒ P.7-19.
Wasserstein M.P., Desnick R.J., Schuchman E.H. Types A and B Niemann–Pick Disease // Lysosomal Storage Disorders, 2013. ‒ C. 80-86.
Pomytkına T., Davydova A. Boleznı nakoplenııa: trýdnostı dıfferentsıalnoı dıagnostıkı // Fýndamentalnaıa ı klınıcheskaıa medıtsına. ‒ 2019. ‒ Vol.4, №2. ‒ P.129-133. [16] Vanier M.T., Patterson M.C. Niemann–Pick Disease Type C // Lysosomal Storage Disorders, 2013. ‒ C. 87-93.
Reuser A.J.J., van der Ploeg A.T. Pompe Disease // Lysosomal Storage Disorders, 2013. ‒ C. 101-106.
Gieselmann V., Wenger D.A., Krägeloh-Mann I. Metachromatic Leukodystrophy and Globoid Cell Leukodystrophy // Lysosomal Storage Disorders, 2013. ‒ C. 70-79.
Barretto C.T., Nascimento M.H.C., Brun B.F. et al. Infrared spectroscopy as a new approach for early fabry disease screening: a pilot study // Orphanet Journal of Rare Diseases. ‒ 2024. ‒ Vol.19, №1. ‒ P.373.
Mehta A., Ramaswami U. Fabry Disease // Lysosomal Storage Disorders, 2013. ‒ C. 58-62.
Bolezn Goshe // Klınıcheskıe protokoly: MZ RK - 2019, ot «12» noıabrıa 2020 goda. [22] Altynshash Jaxybayeva R.K., Lazzat Baygazyieva, Francesca Cainelli. Niemann-Pick disease type C initially misdiagnosed as gaucher disease in a 6 year old kazakh girl // Univrsity Medical Center. ‒ 2017. ‒ URL: URL.
Sheth J., Bhavsar R., Mistri M. et al. Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation // BMC Medical Genetics. ‒ 2019. ‒ Vol.20, №1. ‒ P.31.
Linthorst G.E., Hollak C.E.M. Newborn, High Risk and Carrier Screening for Lysosomal Storage Disorders // Lysosomal Storage Disorders, 2013. ‒ C. 181-185.
Mak J., Cowan T.M. Detecting lysosomal storage disorders by glycomic profiling using liquid chromatography mass spectrometry // Molecular Genetics and Metabolism. ‒ 2021. ‒ Vol.134, №1. ‒ P.43-52.
Tang C., Jia X., Tang F. et al. Detection of glucosylsphingosine in dried blood spots for diagnosis of Gaucher disease by LC-MS/MS // Clinical Biochemistry. ‒ 2021. ‒ Vol.87. ‒ P.79-84.
Hollak C., van Weely S., Van Oers M. et al. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease // The Journal of clinical investigation. ‒ 1994. ‒ Vol.93, №3. ‒ P.1288-1292.
Wolf P., Alcalay R.N., Liong C. et al. Tandem mass spectrometry assay of β-glucocerebrosidase activity in dried blood spots eliminates false positives detected in fluorescence assay // Molecular Genetics and Metabolism. ‒ 2018. ‒ Vol.123, №2. ‒ P.135-139.
Edmond Wraith J., Beck M. Clinical Aspects and Clinical Diagnosis // Lysosomal Storage Disorders, 2013. ‒ C. 13-19.
Legnini E., Orsini J.J., Hung C. et al. Analysis of glucocerebrosidase activity in dry blood spots using tandem mass spectrometry // Clin Chim Acta. ‒ 2011. ‒ Vol.412, №3-4. ‒ P.343-346.
Mao S.-J., Chen Q.-Q., Dai Y.-L. et al. The diagnosis and management of mucopolysaccharidosis type II // Italian Journal of Pediatrics. ‒ 2024. ‒ Vol.50, №1. ‒ P.207.
Giuffrida G., Markovic U., Condorelli A. et al. Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review // Orphanet Journal of Rare Diseases. ‒ 2023. ‒ Vol.18, №1. ‒ P.27.
Cox T.M. Current Treatments // Lysosomal Storage Disorders, 2013. ‒ C. 151-165.
Winchester B., Cox T.M. Other Lysosomal Disorders // Lysosomal Storage Disorders, 2013. ‒ C. 142-149.
d'Azzo A., Bonten E.J. Defect in Protective Protein/Cathepsin A // Lysosomal Storage Disorders, 2013. ‒ C. 115-120.